Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N

被引:24
作者
Kato, T
Akatsu, H
Sato, T
Matsuo, S
Yamamoto, T
Campbell, W
Hotta, N
Okada, N
Okada, H
机构
[1] Nagoya City Univ, Sch Med, Dept Mol Biol, Nagoya, Aichi 4678601, Japan
[2] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan
[3] Nagoya Univ, Sch Med, Dept Internal Med 3, Nagoya, Aichi 4668550, Japan
关键词
rat; carboxypeptidase N (CPN); procarboxypeptidase R (proCPR); TAFI;
D O I
10.1111/j.1348-0421.2000.tb02555.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Carboxypeptidase R (EC 3.4.17.20) (CPR) and carboxypeptidase N (EC 3.4.17.3) (CPN) cleave carboxy-terminal arginine or lysine residues from biologically active peptides such as kinins or anaphylatoxins in the circulation thereby regulating their activities, Although CPN is present in a stable active form in plasma, CPR is generated from proCPR, a plasma zymogen, by proteolytic enzymes such as thrombin, thrombin-thrombomodulin complex and plasmin, We have isolated rat proCPR and CPN cDNA clones which can induce enzymatic activities in culture supernatants of the transfected cells, mRNA of proCPR was detected only in rat liver by Northern hybridization and showed hepatocyte-specific expression. Expression of proCPR mRNA was enhanced following LPS injection, indicating that proCPR production is increased under inflammatory conditions.
引用
收藏
页码:719 / 728
页数:10
相关论文
共 27 条
[1]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[2]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[3]   The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[4]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF VASOACTIVE PEPTIDES DERIVED FROM FIBRIN OR FIBRINOGEN DEGRADED BY PLASMIN [J].
BELEW, M ;
GERDIN, B ;
LINDEBERG, G ;
PORATH, J ;
SALDEEN, T ;
WALLIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 621 (02) :169-178
[5]   Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B) [J].
Boffa, MB ;
Reid, TS ;
Joo, E ;
Nesheim, ME ;
Koschinsky, ML .
BIOCHEMISTRY, 1999, 38 (20) :6547-6558
[6]   Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor [J].
Boffa, MB ;
Bell, R ;
Stevens, WK ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :12868-12878
[7]   ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].
BOKISCH, VA ;
MULLEREB.HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&
[9]   PROTECTION OF RAT ENDOTHELIAL-CELLS FROM PRIMATE COMPLEMENT-MEDIATED LYSIS BY EXPRESSION OF HUMAN CD59 AND/OR DECAY-ACCELERATING FACTOR [J].
CHARREAU, B ;
CASSARD, A ;
TESSON, L ;
LEMAUFF, B ;
NAVENOT, JM ;
BLANCHARD, D ;
LUBLIN, D ;
SOULILLOU, JP ;
ANEGON, I .
TRANSPLANTATION, 1994, 58 (11) :1222-1229
[10]  
EATON DL, 1991, J BIOL CHEM, V266, P21833